The genus Lactobacillus is widely distributed in nature. Several species, including Lactobacillus acidophilus, are components of the normal intestinal flora of healthy humans.
Other species, such as Lactobacillus bulgaricus and Lactobacillus casei, are found in dairy products as well as in fruits and vegetables. The taxonomy is extremely complex, and complete agreement on the designation of specific strains cannot be found.
In some studies it has been shown that when lactobacilli are implanted in the intestinal tract, there seems to be a suppressive effect on other members of the microflora (13, 15) . For example, it has been reported that antibioticassociated diarrhea and colitis have been controlled (5, 11, 15) . The metabolic activation of carcinogens by the intestinal flora of humans and animals is suppressed by feeding them lactobacilli (9) . Similarly, chemically induced colon cancer is reduced in experimental animals given lactobacilli (10) .
Previous investigators have described an antibacterial substance elaborated by certain L. acidophilus strains (4, 7, 11, 15, 16, 18) . Although incompletely characterized, this substance seems to be active principally against other lactobacilli. We describe here a rather different antibacterial substance with broad-spectrum inhibitory properties produced by a human Lactobacillus strain designated GG and isolated and characterized in our laboratory.
MATERIALS AND METHODS
Lactobacillus sp. strain GG was isolated from a healthy person by screening stool specimens for strains that were stable to acid and bile, that adhered to the intestinal mucosa in an in vitro model system (8) The antimicrobial material was active between pH 3 and 5. When the pH was raised to 5.3, the inhibitory activity was lost. Back-titration of the substance to a lower pH allowed the inhibitory effect to be retrieved.
The 10-fold concentrates of GG retained good activity after they were heated at 90°C for 1 h and at 121°C for 15 min. They were also stable to protease inhibitors such as trypsin, proteinase K, oa-chymotrypsin, bromelin, carboxypeptidase A, and S. griseus protease.
The amounts of lactic and acetic acids present in the 10-fold concentrates of three Lactobacillus strains grown in MRS broth, as determined by gas-liquid chromatography determinations, are listed in Table 2 . The concentration of lactic acid in the GG concentrate was 27.54 meq/100 ml, which was the highest concentration among the three Lactobacillus strains tested. The acetic acid concentration of GG concentrate was 5.92 meq/100 ml, which was greater than the concentration produced by strain ADH (kindly supplied by North Carolina State University, Raleigh) but less than that produced by L. bulgaricus. The zones of inhibition against E. coli B-44 obtained at lactic acid concentrations of 50 and 100 meq/100 ml were 4.5 and 7.5 mm, respectively (Table 3) . Similarly, the zones of inhibition with acetic acid were 10 and 8 mm, respectively. The GG 10-fold concentrate produced a zone of inhibition of 12 mm against this organism. When lactic and acetic acids were tested at the concen- Barefoot and Klaenhammer (4) reported a substance produced by L. acidophilus N2 which was active against L. leichmannii, L. helveticus, L. lactis, and L. bulgaricus. It was pH dependent with maximum activity detected in broth cultures at pH 6. This substance was classified as a bacteriocin, because it had a molecular weight of 6,000 to 6,500; however, its activity was restricted to members of the family Lactobacillaceae, and it had a peptide structure.
In 1974, Hamdan and Mikolajcik (11) isolated acidolin from skim milk cultured for 48 h with L. acidophilus. This substance was acidic with a molecular weight of 200 and was inhibitory to enteropathogenic and spore-forming organisms. It also showed limited activity against lactic acid bacteria.
Other antibacterial substances have been isolated from various types of bacteria. Microcins, for example, are produced mostly by members of the family Enterobacteriaceae. First described by Asensio et al. (1) , microcins are peptide antibiotics with low molecular weights. Their production is mediated by plasmids, and they are not inducible by DNAdamaging agents (3) . They are also insensitive to proteases (2) .
In contrast, the bacteriocins, which are inhibitory substances that are generally produced by gram-positive bacteria, have high molecular weights and are susceptible to proteases; and their spectrum of antimicrobial activity is limited to related species (17) .
The inhibitory substance produced by Lactobacillius sp. strain GG, even though it is produced by a gram-positive organism, has a low molecular weight and is active against a broad spectrum of gram-negative and gram-positive organisms, including lactic acid bacteria, but not against other lactobacilli. These characteristics make the substance different from the bacteriocins. It is resistant to various proteases such as proteinase K, ox-chymotrypsin, bromelin, trypsin, and carboxypeptidase A. It is also heat resistant. The low molecular weight and its narrow range of pH preference, in the acidic range, suggest that the antibacterial substance may be a short-chain fatty acid. Certainly, it is not lactic or acetic acid, the principal acids produced by GG according to gas-liquid chromatographic determinations, because the concentrations of these acids required for antibacterial activity were considerably higher than the amounts produced by strain GG. Our laboratory is attempting to characterize and purify this antibacterial substance.
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